Recursion Pharmaceuticals Operating Expenses

Total Operating Expenses of Recursion Pharmaceuticals is 601.86 M USD in 2026.

Total Operating Expenses of Recursion Pharmaceuticals changed from 492.61 M USD to 601.86 M USD, representing a 22.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Recursion Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Recursion Pharmaceuticals historically and in real time.